SEC Form 4 · accession 0001209191-16-133960
INNOVATE BIOPHARMACEUTICALS, INC. · INNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vivek Tandon
Officer — EVP - Operations
Period of report
Jul 7, 2016
Accepted (ET)
Jul 26, 2016 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551986
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 7, 2016 | A | 25,000 | $0.00 | A | 25,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (right to buy)F3,F4 | $4.50 | Jul 7, 2016 | A | 18,000 | A | Jul 7, 2017 | Jul 7, 2026 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1Shares of restricted common stock granted under Issuer's 2012 Omnibus Incentive Plan.
- F2Shares vest one-quarter (1/4) on first anniversary of the grant date and thereafter, one-thirty-six (1/36) vest on the first day of each calendar month.
- F3Employee stock options (right to buy) ("Options") granted under Issuer's 2012 Omnibus Incentive Plan.
- F4Options vest one-quarter (1/4) on first anniversary of the grant date and thereafter, one-thirty-six (1/36) vest on the first day of each calendar month.